U.S. Water Utilities Stock News

Alight (ALIT) opened 2026 with Q1 revenue of US$534 million and a basic EPS loss of US$0.04, alongside a net income loss of US$19 million, setting a cautious tone around profitability. Over the past few quarters, revenue has moved between US$528 million and US$680 million, while basic EPS has ranged from a profit of US$0.05 to losses of more than US$2.00 per share, underlining how pressure on earnings has weighed on the story. For investors, the latest numbers keep the focus squarely on...

Wondering if Monarch Casino & Resort at around US$117.63 is offering fair value or if expectations have run ahead of the business? This article breaks down what the current price might be implying. The stock has been volatile in the short term, with a 1.4% decline over the last 7 days, but sits on gains of 19.8% over 30 days, 22.5% year to date and 50.0% over the past year, plus 83.1% over 3 years and 92.4% over 5 years. Recent price moves are occurring against a backdrop of ongoing interest...

Schrödinger (SDGR) has opened 2026 with Q1 revenue of US$58.6 million, a basic EPS loss of US$0.81 and a net loss of US$60.0 million, while on a trailing twelve month basis revenue stands at US$254.9 million with a basic EPS loss of US$1.40 and a net loss of US$103.5 million. Over recent quarters, revenue has moved between US$54.3 million and US$88.3 million, with quarterly basic EPS ranging from a profit of US$0.44 to a loss of US$0.82, which leaves investors weighing top line scale against...

J&J Snack Foods (JJSF) has reported Q2 2026 results with revenue of US$344.8 million and basic EPS of US$0.09, alongside net income of US$1.7 million. The company has seen recent revenue move from US$356.1 million in Q2 2025 to US$344.8 million in Q2 2026, while basic EPS shifted from US$0.25 to US$0.09 over the same period. This sets the stage for investors to focus closely on how earnings quality and margins are developing. See our full analysis for J&J Snack Foods. With the latest figures...

Unisys (UIS) opened 2026 with Q1 revenue of US$437.6 million and a basic EPS loss of US$0.50, compared with Q1 2025 revenue of US$432.1 million and a basic EPS loss of US$0.42. Over the last year, revenue across the reported quarters has ranged from US$432.1 million to US$574.5 million, while basic EPS has swung between a profit of US$0.26 and a loss of US$4.33. This sets up this quarter as another test of how the company manages its margins under uneven earnings pressure. See our full...

Renasant Corporation recently completed a US$300,000,000 Fixed‑to‑Floating Rate Subordinated Notes offering due 2036, priced at 100% with a 6.25% coupon transitioning to a SOFR‑linked floating rate and intended to qualify as Tier 2 regulatory capital. The deal’s junior, subordinated and unsecured structure, combined with potential redemption of existing subordinated notes, reshapes Renasant’s capital stack and future funding flexibility. We’ll now examine how this Tier 2 capital raise and...

NiSource (NI) has just opened 2026 with Q1 revenue of US$2.4b and basic EPS of US$1.07, setting the tone for how its earnings story is evolving against the backdrop of its recent history. Over the last few quarters, the company has seen revenue move from US$1.6b in Q4 2024 to US$2.4b in Q1 2026. Quarterly basic EPS has ranged from US$0.20 to just over US$1.00, giving investors a clear view of how earnings scale with the top line. With trailing twelve month EPS at US$2.03 and net profit margin...

Relay Therapeutics (RLAY) opened 2026 with Q1 revenue of US$3 million, basic EPS of a US$0.41 loss, and a net loss excluding extra items of US$73.3 million, setting a clear snapshot of where the business is starting the year. The company has seen quarterly revenue move between US$0 and US$7.7 million since early 2024, while basic EPS has ranged from a US$0.32 loss to a US$0.46 loss over the same period, giving investors a consistent view of a revenue generating but loss making biotech with...

FormFactor (FORM) has opened 2026 with Q1 revenue of US$226.1 million and basic EPS of US$0.26, alongside trailing 12 month revenue of US$839.8 million and basic EPS of US$0.88 that reflect the latest reported earnings base. The company has seen quarterly revenue move from US$171.4 million in Q1 2025 to US$226.1 million in Q1 2026, with basic EPS shifting from US$0.08 to US$0.26 over the same period, setting up a results season in which investors can weigh that earnings profile against the...

If you are wondering whether Pfizer at a last close of US$26.53 still offers solid value, the starting point is understanding what that price really implies about the business. Over the last year the stock returned 24.9%, with a 5.4% gain year to date, a 1.0% rise over the past week, and a 4.7% decline across the last 30 days, which signals that expectations and perceived risk have been shifting recently. Recent headlines have focused on Pfizer's efforts to reshape its portfolio and...

Fabrinet (FN) has just posted Q3 2026 results with revenue of US$1.2 billion, basic EPS of US$3.49 and net income of US$125.2 million, against a backdrop of 29% reported earnings growth over the last year and a trailing 12 month earnings growth rate of 19.2% per year over the past five years. The company has seen revenue move from US$871.8 million in Q3 2025 through US$909.7 million in Q4 2025 and US$978.1 million in Q1 2026 to US$1.2 billion in Q3 2026. Over the same span, basic EPS has gone...

Astera Labs (ALAB) has put up another active quarter, with Q1 2026 revenue of US$308.4 million and basic EPS of US$0.47, at a time when trailing 12 month EPS sits at US$1.59 on revenue of about US$1.0 billion and net income of US$267.6 million. This comes alongside very large year on year earnings growth and higher profit margins over the past year. Over the last five reported quarters, revenue has moved from US$159.4 million in Q1 2025 to US$308.4 million in Q1 2026, while quarterly EPS has...

Jacobs Solutions (J) opened Q2 2026 with revenue of about US$3.7b and a basic EPS loss of US$0.32, putting a negative earnings print alongside a higher top line. The company has seen quarterly revenue move from about US$2.9b in Q2 2025 to about US$3.7b in Q2 2026, while basic EPS shifted from US$0.10 in Q2 2025 to a loss of US$0.32 this quarter, setting up a mixed read on growth versus profitability that puts the spotlight firmly on margins and earnings quality. See our full analysis for...

Marqeta (MQ) has just posted its Q1 2026 scorecard, reporting revenue of US$165.8 million and basic EPS of US$0.02, with the trailing twelve months showing total revenue of US$651.6 million and basic EPS of US$0.00. Over recent quarters, revenue has ranged from US$135.8 million in Q4 2024 to US$172.1 million in Q4 2025, while quarterly basic EPS has moved from a loss of US$0.05 in Q4 2024 to a profit of US$0.02 in Q1 2026. This sets up a results season in which the key question for investors...

Edgewell Personal Care (EPC) has put fresh numbers on the table for Q2 2026, reporting revenue of US$519.5 million and basic EPS of US$0.09. This comes against a backdrop of trailing 12 month revenue of US$2.2 billion and a basic EPS loss of US$0.23. Over the past few quarters the company has seen revenue move between US$415.1 million and US$627.2 million, while basic EPS has swung from a loss of US$0.66 to a profit of US$0.62. This performance sets the scene for investors to focus on how...

Belden Inc. has reported past first-quarter 2026 results, with sales rising to US$696.38 million and GAAP diluted EPS from continuing operations at US$1.30, and has also issued second-quarter 2026 guidance for revenues of US$735 million to US$750 million and GAAP EPS of US$1.53 to US$1.63. Together with progress on its Joseph C. Belden Innovation Award finalists, these figures highlight how Belden is pairing earnings stability with initiatives that promote IT/OT convergence and data-driven...

California Resources (CRC) opened 2026 with Q1 revenue of US$967 million and a basic EPS loss of US$8.02 per share, setting a stark headline for the latest quarter. The company has seen quarterly revenue move between US$798 million and US$926 million over the last year, while EPS shifted from a profit of US$1.93 in Q2 2025 to smaller profits in subsequent quarters before this latest loss. This leaves investors weighing solid top line scale against pressure on margins. See our full analysis...

MasterBrand (MBC) opened Q1 2026 with revenue of US$618 million and a basic EPS loss of US$0.12, while trailing 12 month figures show revenue of about US$2.7 billion and a marginal basic EPS loss of US$0.02, underscoring pressure on profitability. Over recent quarters the company has seen revenue move between US$660.3 million in Q1 2025 and US$730.9 million in Q2 2025, alongside basic EPS shifting from a profit of US$0.29 in Q2 2025 to a loss of US$0.33 in Q4 2025. This sets the stage for...

Veracyte (VCYT) just posted Q1 2026 results with revenue of US$139.1 million and basic EPS of US$0.36, while trailing 12 month figures show revenue of US$541.7 million and basic EPS of US$1.11, alongside a 166.3% year over year earnings increase and net margins at 16.2% versus 7.1% a year earlier. Over recent quarters the company has seen revenue move from US$114.5 million in Q1 2025 to US$139.1 million in Q1 2026, with basic EPS ranging from US$0.09 to US$0.52 in interim periods. This sets...

Jazz Pharmaceuticals (JAZZ) opened 2026 with Q1 revenue of US$1.1 billion and basic EPS of US$4.74, setting a clear marker against last year’s volatile run of quarterly results. Over recent quarters the company has seen revenue move from US$897.8 million in Q1 2025 to US$1.09 billion in Q4 2024 and then to US$1.07 billion in Q4 2025. Basic EPS has shifted from a loss of US$1.52 per share in Q1 2025 to US$3.16 in Q4 2024 and US$3.33 in Q4 2025, leaving investors focused on how much of the...

Deluxe (DLX) opened 2026 with Q1 revenue of US$538.1 million and basic EPS of US$0.77. Trailing 12 month figures show revenue of US$2.1 billion and EPS of US$2.31, supported by 85.5% earnings growth over the past year. Over recent quarters the company has seen revenue fluctuate in a tight band between US$520.6 million and US$540.2 million, with basic EPS ranging from US$0.26 to US$0.77, and net profit margins over the last 12 months running at 4.9% versus 2.6% in the prior year. This sets up...

Vontier (NYSE:VNT) highlighted its multi energy fleet technology strategy at ACT Expo 2026. The company presented an integrated platform that combines traditional and new energy refueling, EV management, diagnostics, payment security, and telematics. The event showcased new solutions aimed at supporting fleet decarbonization and digital transformation. For investors tracking the fleet and mobility sector, Vontier sits at the intersection of hardware, software, and services for...

Kyndryl Holdings (KD) just closed FY 2026 with fourth quarter revenue of US$3.8b and basic EPS of US$0.08, alongside trailing 12 month revenue of US$15.1b and EPS of US$0.87 that frame the full year picture. Over recent quarters, revenue has moved in a tight band from US$3.7b to US$3.9b while quarterly EPS has ranged from US$0.24 to US$0.29 before landing at US$0.08 in Q4, giving you a clear sense of how earnings have tracked against a largely steady top line. With a trailing net profit...

Primoris Services (PRIM) opened 2026 with Q1 revenue of US$1.6b and basic EPS of US$0.32, setting the tone for how its construction and infrastructure pipeline is feeding through to the bottom line. Over the past year, revenue has moved from US$1.6b in Q1 2025 to US$1.9b in Q2 2025, US$2.2b in Q3 2025, US$1.9b in Q4 2025 and US$1.6b in Q1 2026, while quarterly basic EPS has ranged from US$0.82 to US$1.75 across those periods. For investors, a key focus is how these volumes are translating...